Your browser doesn't support javascript.
loading
Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance).
Chen, Ronald C; Choueiri, Toni K; Feuilly, Marion; Meng, Jie; Lister, Johanna; Marteau, Florence; Falchook, Aaron D; Morris, Michael J; George, Daniel J; Feldman, Darren R.
Afiliación
  • Chen RC; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, Kansas.
  • Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts.
  • Feuilly M; Department of Oncology, Ipsen Pharma SAS, Boulogne-Billancourt Cedex, France.
  • Meng J; Analytica Laser, Lörrach, Germany.
  • Lister J; Analytica Laser, Lörrach, Germany.
  • Marteau F; Department of Oncology, Ipsen Pharma SAS, Boulogne-Billancourt Cedex, France.
  • Falchook AD; Department of Radiation Oncology, Memorial Cancer Institute, Pembroke Pines, Florida.
  • Morris MJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • George DJ; Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, Kansas.
  • Feldman DR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer ; 126(24): 5311-5318, 2020 12 15.
Article en En | MEDLINE | ID: mdl-33022096

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Carcinoma de Células Renales / Sunitinib / Neoplasias Renales / Anilidas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Carcinoma de Células Renales / Sunitinib / Neoplasias Renales / Anilidas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2020 Tipo del documento: Article